Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
EDAP
#3093
EDAP TMS SA
4.3
7
-1.80%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-1.80%
Changement Mensuel
+5.56%
Evolution sur 6 mois
+173.12%
Changement Annuel
+65.53%
Clôture Précédente
4.4
5
Open
4.3
7
Bid
Ask
Low
4.3
7
High
4.3
7
Volume
2
Marchés
Actions des Marchés US
Soins de Santé
EDAP
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
Q4, 24
TTM
Key stats
Total common shares outstanding
37.39 M
144.87 M
Valuation ratios
Enterprise value
82.64 M
865.47 M
Price to earnings ratio
-4.33
169.85
Price to sales ratio
—
—
Price to cash flow ratio
—
—
Price to book ratio
—
—
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
—
—
Return on equity %
—
—
Return on invested capital %
—
—
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
—
—
Current ratio
—
—
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
—
—
Long term debt to total equity ratio
—
—
Per share metrics
Operating cash flow per share
—
—
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
—
—
Cash per share
—
—
Net current asset value per share
—
—
Tangible book value per share
—
—
Working capital per share
—
—
Book value per share
—
—
Nouvelles
EDAP annonce un chiffre d’affaires HIFU record et des prévisions solides pour 2026
EDAP reports record HIFU revenue, issues strong 2026 guidance
RBOT Enters Strategic Software Partnership to Streamline Development
AngioDynamics: Growth Remains Under The Radar (NASDAQ:ANGO)
EW Wins FDA Approval for SAPIEN M3 as First Transseptal TMVR Therapy
ISRG Gets FDA Clearance to Use da Vinci SP Robot for General Surgeries
EDAP reçoit l’autorisation de la FDA pour son système robotique HIFU Focal One amélioré
EDAP receives FDA clearance for enhanced Focal One robotic HIFU system
L’objectif de prix de l’action EDAP TMS relevé à 2,00$ contre 1,80$ chez Jefferies
EDAP TMS stock price target raised to $2.00 from $1.80 at Jefferies
Le BPA de EDAP a dépassé les attentes de 0,08€, le CA a surpassé les prévisions
EDAP earnings beat by €0.08, revenue topped estimates